Literature DB >> 7256525

Neurological response to hyperbaric oxygen--a criterion for cerebral revascularization.

J P Kapp.   

Abstract

Twenty-two patients with cerebral infarction secondary to occlusion of a carotid or middle cerebral artery were exposed to hyperbaric oxygen at 1.5 atmospheres absolute pressure. Ten of the patients demonstrated improved motor function during hyperbaric exposure. Seven of these patients had successful surgical revascularization and no recurrence of neurological deficit. In 3 patients who were not successfully revascularized, the neurological deficit recurred. It is concluded that response to hyperbaric oxygen may be of use in the selection of patients with neurological deficit who will benefit from surgical revascularization of the brain.

Entities:  

Mesh:

Year:  1981        PMID: 7256525     DOI: 10.1016/s0090-3019(81)80089-4

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  4 in total

1.  Oxygen-sensitive outcomes and gene expression in acute ischemic stroke.

Authors:  Cameron Rink; Sashwati Roy; Mahmood Khan; Pavan Ananth; Periannan Kuppusamy; Chandan K Sen; Savita Khanna
Journal:  J Cereb Blood Flow Metab       Date:  2010-02-10       Impact factor: 6.200

Review 2.  Neurological improvement in chronic ischemic stroke following surgical brain revascularization.

Authors:  G F Rossi; G Maira; A Vignati; A Puca
Journal:  Ital J Neurol Sci       Date:  1987-10

3.  An anxiolytic-like effect of hyperbaric oxygen in the mouse light/dark exploration test.

Authors:  Edina L Carlile; Donald Y Shirachi; Raymond M Quock
Journal:  Life Sci       Date:  2011-12-01       Impact factor: 5.037

4.  Hyperbaric oxygen prevents early death caused by experimental cerebral malaria.

Authors:  Yara C Blanco; Alessandro S Farias; Uta Goelnitz; Stefanie C P Lopes; Wagner W Arrais-Silva; Bruna O Carvalho; Rogério Amino; Gerhard Wunderlich; Leonilda M B Santos; Selma Giorgio; Fabio T M Costa
Journal:  PLoS One       Date:  2008-09-04       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.